Please assess the completion status of the following clinical trial:

Trial Title: Treating Alzheimer's and Dementia With D-ribose

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance.~* Must have a caregiver living with them.~Exclusion Criteria:~* Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.~* Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment with d-ribose (Type: EXPERIMENTAL): Treatment with ribose 5 gm TID

Based on this trial design, predict the completion outcome and termination type (if applicable).